Changes in Immunoglobulin in Patients with Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies

被引：0
|
作者：
Vollmer, Brandi [1 ]
Bourassa, Timber [1 ]
Dao, Vi [1 ]
Sillau, Stefan [1 ]
Alvarez, Enrique [1 ]
Nair, Kavita [1 ,2 ]
机构：
[1] Univ Colorado, Dept Neurol, Aurora, CO USA
[2] Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P286/714
引用
收藏
页码：340 / 340
页数：1
相关论文
共 50 条
  • [1] Anti-CD20 monoclonal antibodies in multiple sclerosis
    Moreno Torres, Irene
    Garcia-Merino, Antonio
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (04) : 359 - 371
  • [2] CD20 monoclonal antibodies for the treatment of multiple sclerosis: up-to-date
    Ancau, Mihai
    Berthele, Achim
    Hemmer, Bernhard
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (08) : 829 - 843
  • [3] Rebound of multiple sclerosis in patients treated with anti CD20 after discontinuation of rituximab
    Missione, Rosanna
    Signoriello, Elisabetta
    Bonavita, Simona
    Lus, Giacomo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [4] Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
    Shiv Saidha
    Judith Bell
    Sydney Harold
    Jose Marcano Belisario
    Emma Hawe
    Qiujun Shao
    Kerri Wyse
    Eric M. Maiese
    Neurological Sciences, 2023, 44 : 1515 - 1532
  • [5] Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
    Saidha, Shiv
    Bell, Judith
    Harold, Sydney
    Belisario, Jose Marcano
    Hawe, Emma
    Shao, Qiujun
    Wyse, Kerri
    Maiese, Eric M.
    NEUROLOGICAL SCIENCES, 2023, 44 (05) : 1515 - 1532
  • [6] Anti CD20 monoclonal antibodies in PTI symtomatic refractories
    Parodi, E.
    Rivetti, E.
    Amendola, G.
    Bisogno, G.
    Di Concilio, R.
    Faruggia, P.
    Giordano, P.
    Licciardello, M.
    Matarese, S. M. R.
    Nardi, M.
    Nobili, B.
    Notarangelo, L.
    Russo, G.
    Vimercati, C.
    Zecca, M.
    De Mattia, D.
    Ramenghi, U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : S46 - S46
  • [7] A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
    Esther S. Frisch
    Roxanne Pretzsch
    Martin S. Weber
    Neurotherapeutics, 2021, 18 : 1602 - 1622
  • [8] Monoclonal antibodies targeting CD20
    Chang, Chien-Hsing
    Rossi, Edmund A.
    Goldenberg, David M.
    MABS, 2013, 5 (03) : 335 - 336
  • [9] Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
    Finn Sellebjerg
    Morten Blinkenberg
    Per Soelberg Sorensen
    CNS Drugs, 2020, 34 : 269 - 280
  • [10] Anti-CD20 Monoclonal Antibodies for Relapsing and Progressive Multiple Sclerosis
    Sellebjerg, Finn
    Blinkenberg, Morten
    Sorensen, Per Soelberg
    CNS DRUGS, 2020, 34 (03) : 269 - 280
12345